Skip to main content
Equibles

Dodge & Cox

Position in REGN — Regeneron Pharmaceuticals, Inc.

CIK 200217 San Francisco, CA
Back to REGN Full portfolio

Position in REGN

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$3,037,348,764
-$407,264,244 QoQ
Shares Held
4,871,137
+9.3% QoQ
Ownership
4.73%
of shares outstanding
% of Portfolio
1.59%
of 13F equity value
Holder Rank
#3
of 1,329 holders
Holding Since
Dec 2021
19 quarters on record
Voting authority Sole 95% Shared 0% None 5%

Common Shares in REGN Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Dodge & Cox holds $6,173,089,929 across 5 Biotechnology names. REGN ranks #1 (49.2% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 REGN
Regeneron Pharmaceuticals, Inc.
This page 		4,871,137 $3,037,348,764
2 INCY
Incyte Corp
 11,957,326 $1,355,482,475
3 BMRN
Biomarin Pharmaceutical Inc
 14,844,930 $849,426,894
4 ALNY
Alnylam Pharmaceuticals, Inc.
 1,955,393 $588,631,954
5 BNTX
BioNTech SE
 3,677,591 $342,199,842

All Filings in REGN

Export CSV
19 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $3,037,348,764 4,871,137
2026-03-31 $3,444,613,008 4,458,238
2025-12-31 $3,547,790,849 4,596,358
2025-09-30 $2,558,803,618 4,550,845
2025-06-30 $2,008,798,575 3,826,283
2025-03-31 $1,474,004,429 2,324,085
2024-12-31 $1,653,543,026 2,321,316
2024-09-30 $2,430,398,549 2,311,935
2024-06-30 $2,433,855,456 2,315,686
2024-03-31 $2,271,345,501 2,359,864
2023-12-31 $2,079,509,667 2,367,680
2023-09-30 $1,952,882,434 2,372,998
2023-06-30 $1,720,439,841 2,394,355
2023-03-31 $1,959,437,270 2,384,701
2022-12-31 $1,603,914,837 2,223,059
2022-09-30 $1,575,107,454 2,286,509
2022-06-30 $1,339,106,887 2,265,334
2022-03-31 $1,562,409,540 2,237,063
2021-12-31 $176,271,125 279,122